DLBS2411 Treatment For Functional Dyspepsia

PHASE3RecruitingINTERVENTIONAL
Enrollment

106

Participants

Timeline

Start Date

December 9, 2022

Primary Completion Date

June 30, 2025

Study Completion Date

August 31, 2025

Conditions
Functional Dyspepsia
Interventions
DRUG

Placebo caplet of DLBS2411

1 caplet of placebo DLBS2411, twice daily

DRUG

DLBS2411

1 caplet of DLBS2411 250 mg, twice daily

Trial Locations (8)

10430

RECRUITING

Division of Gastroenterology Department of Internal Medicine Faculty of Medicine, University of Indonesia Dr. Cipto Mangunkusumo National General Hospital, Jakarta

Unknown

RECRUITING

Department of Internal Medicine, Dr. Kariadi General Hospital, Semarang

RECRUITING

Department of Internal Medicine, Universitas Sebelas Maret (UNS) Hospital, Sukoharjo

RECRUITING

Department of Internal Medicine, Dr. Moewardi Hospital, Surakarta

SUSPENDED

Department of Internal Medicine, Budhi Asih Hospital, Jakarta

RECRUITING

Department of Internal Medicine, Fatmawati General Hospital, Jakarta

RECRUITING

Department of Internal Medicine, Pasar Rebo Hospital, Jakarta

NOT_YET_RECRUITING

Department of Internal Medicine, Dr. Soetomo General Hospital, Surabaya, Indonesia, Surabaya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Dexa Medica Group

INDUSTRY

NCT05248802 - DLBS2411 Treatment For Functional Dyspepsia | Biotech Hunter | Biotech Hunter